Alvine Pharmaceuticals Initiates Phase I Trial For ALV003
Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, announced that the first study subject was dosed in a Phase 1 clinical trial of its lead clinical candidate ALV003 which is in development for the treatment of patients with celiac disease. ALV003 is an orally administered combination of two proteases engineered to detoxify gluten.
AP - Russian forces turned over 12 Georgian soldiers on the border of one of the separatist provinces under its control Thursday after the short war that outraged the West and brought Moscow's military deep into Georgia.
AP - Sen. Barack Obama dropped in on his own party at the Democratic convention a day early Wednesday to praise his wife, his former rival, and former President Bill Clinton for going to bat for him.
